Uncategorized
NovaBay Pharmaceuticals to Hold First Quarter 2019 Conference Call on May 9, 2019
EMERYVILLE, Calif.--(BUSINESS WIRE)--lt;a href="https://twitter.com/hashtag/blepharitis?src=hash" target="_blank"gt;#blepharitislt;/agt;--NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, announces that it will report first quarter 2019 financial results after market close on Thursday, May 9, 2019 and will hold an investment community conference call that day. In addition to discussing financial results during the call, management will provide updates on recent initiatives to incr